A6226

AM251

>98% (HPLC), solid, cannabinoid receptor (CB1) antagonist

• Synonim(y): 1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide
• Wzór empiryczny (zapis Hilla): C₂₂H₂₁N₄OCl₂I
• Numer CAS: 183232-66-8
• Masa cząsteczkowa: 555.24
• UNSPSC Code: 12352200
• PubChem Substance ID: 24891069
• NACRES: NA.77
• MDL number: MFCD01861181
• Assay: >98% (HPLC)
• Form: solid

Właściwości

• Nazwa produktu: AM251, >98% (HPLC), solid
• Quality Segment: 100
• assay: >98% (HPLC)
• form: solid
• color: white
• solubility: DMSO: >10 mg/mL, H₂O: insoluble
• originator: Sanofi Aventis
• SMILES string: Cc1c(nn(-c2ccc(Cl)cc2Cl)c1-c3ccc(I)cc3)C(=O)NN4CCCCC4
• InChI: 1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)
• InChI key: BUZAJRPLUGXRAB-UHFFFAOYSA-N
• Gene Information: mouse ... Cnr1(12801), Cnr2(12802) ; rat ... Cnr1(25248)

Opis

Application

AM251, a CB₁ cannabinoid receptor antagonist, has been used in a study to determine its interaction with hippocampal neurons to enhance spatial memory in mice.

Biochem/physiol Actions

AM251 is a CB₁ cannabinoid receptor antagonist.

Features and Benefits

This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Other Notes

Salt content may vary.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Kody zagrożeń: H413
• Ostrzeżenia: P273 - P501
• Hazard Classifications: Aquatic Chronic 4
• Klasa składowania: 11 - Combustible Solids
• Co się dzieje?: WGK 3
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable
• PPE (środki ochrony indywidualnej): dust mask type N95 (US), Eyeshields, Gloves